The overlooked reason why new drugs take so long—and the $10 trillion fix
Cutting just one year from the Food and Drug Administration's drug review process could create more than $10 trillion in economic value while getting lifesaving medicines to patients faster, according to a new report calling for major FDA reforms.The report, The Multi-Trillion Dollar Opportunity in Reforming the FDA, published by the free-market policy group Unleash Prosperity, argues that lengthy effectiveness reviews, not safety testing, account for much of the agency's […]
